Accumulation of cytochrome P450 induced by proteasome inhibition during cardiac ischemia.

Increasing evidence shows that cytochrome P450 (CYP) contributes to cardiac reperfusion injury. However, there have been few reports about the roles of CYPs in cardiac ischemia. The aim of the present study was to investigate the CYP expression and activity during ischemia using an in vivo rat model of myocardial infarction.

Effects of sulfaphenazole derivatives on cardiac ischemia-reperfusion injury: association of cytochrome P450 activity and infarct size.

Cardiac ischemia-reperfusion injury is evoked by reactive oxygen species (ROS). We previously reported that sulfaphenazole (SPZ) attenuated cardiac ROS levels and ischemia-reperfusion injury in rats. SPZ has distinct two actions: a) elimination of ROS and b) inhibition of cytochrome P450 (CYP) that is responsible for ROS production.

Suppression of myocardial ischemia-reperfusion injury by inhibitors of cytochrome P450 in rats.

The effects of inhibitors of cytochrome P450 on myocardial regional ischemia-reperfusion injury were examined in rats. Ischemia-reperfusion injury was evoked by ligation of the left anterior descending coronary artery for 1 h, followed by reperfusion for 24 h. Injuries were evident in causing infarction, decreases in left ventricular systolic pressure and left ventricle (dP/dt max)/P and an increase in left ventricular end-diastolic pressure.

Sustained contraction and endothelial dysfunction induced by reactive oxygen species in porcine coronary artery.

A combination of purine and xanthine oxidase (XOD) dose-dependently elicited sustained contraction of porcine coronary arterial rings and resulted in increased concentrations of superoxide anions and hydrogen peroxide. These contractile responses appeared, with a delay, after the application of purine and XOD, used as a reactive oxygen species (ROS)-generating system. Coronary arteries precontracted with prostaglandin F(2alpha) failed to relax in response to substance P after exposing the arterial preparation to this ROS-generating system.